SCHEMBL7965736

SCHEMBL7965736

C[C@H](OCc1ccccc1)C(N)CN

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.45
SLC1A2 P43004 2/20 0.45
SLC1A1 P43005 2/20 0.45
CYP2D6 P10635 2/20 0.45
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
TAAR1 Q96RJ0 3/20 0.44
SLC6A2 P23975 2/20 0.44
MAOA P21397 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CYP2A6 P11509 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
TACR1 P25103 3/20 0.43
RCE1 Q9Y256 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965733 1.00 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL7965740 1.00 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL14195280 0.85 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL4099990 0.85 ANPEP (0.46) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL5679211 0.85 ANPEP (0.46) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL17833682 0.85 ANPEP (0.46) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL20194387 0.85 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL13696735 0.85 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
SCHEMBL29250597 0.85 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1CYP2D6MEN1
Hydrochloric Acid SCHEMBL5681286 0.84 ANPEP (0.44) SLC1A3SLC1A2SLC1A1CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274715-B1 SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY ABBOTT LABORATORIES 2001-08-14 US disclosed
EP-0961776-A1 TRICYCLIC ERYTHROMYCIN DERIVATIVES Abbott Laboratories (US) 1999-12-08 EP disclosed
WO-1998030574-A1 TRICYCLIC ERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1998-07-16 WO disclosed